Mamoru et al. reported that IL-7 and IL-12 expression of recombinant vaccinia viruses increased tumor-infiltrating lymphocytes in the LLC lung cancer model, leading to a better tumor therapy efficacy than IL-12 alone. This evidence concerns the gene IL7 and lung carcinoma.